Global Biopharmaceutical Company Stays Secure With Security Information and Event Management System
Global biopharmaceutical is a leading pharmaceutical company, with headquartered in the United States. The organization is challenged with continuing security audits of its network and data security systems by its partner companies and the Federal Drug Administration (FDA). The company needed a Security Information and Event Management (SIEM) system that takes massive volumes of data logs from all of the company's security devices and gathers them into a central repository. As a long-time Check Point customer, the pharmaceutical company has a substantial standing investment in VPN-1 technology. With Eventia Analyzer, the company is able to correlate log data from Check Point security devices-as well as third-party security devices-automatically prioritizing security events for decisive, intelligent action.